🍭 Metabolic Health & Prediabetes

What this panel can settle, and by what logic

Eight markers, and the reason they are bought together is that they stage the same disease at four different distances from it.

1. Fasting Insulin beside the glucose on the Comprehensive Metabolic Panel (CMP) separates compensation from failure. A glucose of 92 mg/dL with an insulin of 4 µIU/mL and a glucose of 92 mg/dL with an insulin of 18 µIU/mL are the same glucose and opposite situations: in the second, normal glucose is being bought with four times the insulin. Neither HbA1c (Hemoglobin A1c) nor a glucose reading can show that, because both report the result and not the effort Krhač 2019.
2. The Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) earns its place here as a ratio, not as cholesterol. Triglycerides divided by HDL is the cheapest insulin resistance surrogate on the list, and it moves in the same direction as the insulin does, which is what makes two $9 tests corroborate a $10 one.
3. Uric Acid is often the first value out of range. It rises with fructose intake and with hyperinsulinemia, and on this panel it usually moves before the glucose does — which is the entire argument for buying a panel rather than a glucose test.
4. Ferritin read with hs-CRP (High-Sensitivity C-Reactive Protein) and the ALT on the Comprehensive Metabolic Panel (CMP) is a specific pattern, not a spare marker. A raised ferritin with metabolic syndrome and no genetic iron loading has a name and a definition of its own Valenti 2023, and it points at the liver rather than at iron overload. Alanine aminotransferase in the same reading predicts incident steatotic liver disease Lonardo 2024, so three markers already on the list say something together that none of them says alone.

What it cannot settle, and what would

It cannot see the excursion after a meal, and that is the part that does the damage. HbA1c (Hemoglobin A1c) is an average over 2 to 3 months Chen 2022, and an average deletes the spikes that produced it. Continuous glucose monitoring in healthy nondiabetic adults found every index of glycemic variability higher in the prediabetes group than in the healthy group Kashiwagi 2023, which is a difference this panel reports as two normal numbers. A 14-day sensor costs about the same as this panel and answers the question this panel structurally cannot.

It cannot diagnose diabetes, because one abnormal result is not a diagnosis. A single HbA1c of 6.6% requires confirmation on a second sample before it means anything, and the reason is analytical as much as biological: the value depends on red cell lifespan and on globin chain structure as well as on glucose Chen 2022.

It cannot see liver fat. The Comprehensive Metabolic Panel (CMP) carries ALT and ALT is genuinely informative about future risk Lonardo 2024, but a normal ALT does not exclude steatosis in a large fraction of people who have it. Ultrasound, and better, an MRI-derived fat fraction, is what sees fat in a liver.

And it cannot tell you whether the insulin resistance is hepatic or peripheral, which is the difference between a liver problem and a muscle problem. That separation needs a clamp study and does not exist at consumer prices Krhač 2019.

Draw conditions that decide whether the money is wasted

Half of this panel is fasting-dependent and half of it is not, and the half that is, is the half you bought it for.

1. 9 to 12 hours, water only. Fasting Insulin and triglycerides are both meaningless fed: insulin rises within minutes of carbohydrate and stays up for hours, so a $10 marker chosen to detect a decade-long process instead reports breakfast Krhač 2019. Coffee with milk breaks the fast for this purpose; black coffee does not.
2. No hard training in the 48 hours before. A heavy session improves insulin sensitivity acutely, which is the one direction that makes a bad result look acceptable, and it also lifts hs-CRP (High-Sensitivity C-Reactive Protein) and the ALT on the Comprehensive Metabolic Panel (CMP) at the same time.
3. Not within 2 weeks of an illness. Ferritin and hs-CRP are both acute-phase proteins and rise together, so the pattern that would otherwise mean metabolic hyperferritinemia is unreadable Luo 2023 Valenti 2023.
4. HbA1c (Hemoglobin A1c) does not need a fast and cannot be gamed by one. Three days of clean eating before a draw moves the fasting glucose and the insulin and leaves the HbA1c where it was, because it integrates the preceding months Chen 2022. That mismatch is diagnostic in itself.

How you would know it answered your question, and what each pattern means next

Five patterns. The retest interval is set by the marker, not by impatience.

• Normal glucose with Fasting Insulin above 8 to 10 µIU/mL: the reversible stage, and the reason to have bought this. Change diet and training, then retest insulin and triglycerides at 12 weeks Krhač 2019.
• HbA1c (Hemoglobin A1c) 5.7 to 6.4%: confirm on a second sample, then retest no sooner than 3 months. Anything earlier is reading blood cells that were already glycated when you changed what you were doing Chen 2022.
• Raised Uric Acid with normal glucose and normal insulin: the earliest signal on the panel. Recheck at 12 weeks alongside the insulin rather than treating it as a gout question.
• Raised Ferritin with a raised ALT and a normal hs-CRP (High-Sensitivity C-Reactive Protein): read it as metabolic rather than as iron overload Valenti 2023, and the next test is a liver-directed one Lonardo 2024, not a hemochromatosis panel.
• Everything normal and the symptoms are real: the panel has excluded the slow version of the problem, and what is left is the fast one it cannot see. That is a sensor, not a second panel Kashiwagi 2023.

Sources read for these sections

• Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World Journal of Diabetes 2019 · PMID 30697366
• Chen Z, et al. Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review). Experimental and Therapeutic Medicine 2022 · PMID 36382101
• Kashiwagi K, et al. Assessment of glycemic variability and lifestyle behaviors in healthy nondiabetic individuals according to the categories of body mass index. PLoS One 2023 · PMID 37792730
• Valenti L, et al. Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nature Reviews Endocrinology 2023 · PMID 36805052
• Lonardo A. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!. World Journal of Gastroenterology 2024 · PMID 38983954
• Luo H, et al. A Practical Guide to Adjust Micronutrient Biomarkers for Inflammation Using the BRINDA Method. Journal of Nutrition 2023 · PMID 36792034